All In Biotech

Drug Trial Radar · NCT02983227

A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350

A Phase II Open-Label Extension Study of Patients Previously Enrolled in Study GA29350 to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Patients With Moderate to Severe Rheumatoid Arthritis

Last checked: Nov 19, 2026Latest source record: Aug 3, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

496

Actual

Start

Nov 30, 2016

Primary completion

Jul 17, 2019

Study completion Jul 17, 2019

Sponsor

Lead sponsor
Genentech, Inc.Roche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Dec 6, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 76 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study to evaluate the long-term safety and efficacy of GDC-0853 in participants with moderate to severe active Rheumatoid Arthritis (RA) who have completed 12 weeks of study treatment in Study GA29350. Eligible participants from Study GA29350 who elect to participate will receive treatment with GDC-0853 twice daily (BID) in an open-label fashion for 52 weeks, followed by a safety follow-up period of 8 weeks.

Conditions

  • Rheumatoid Arthritis

Interventions

  • GDC-0853Drug

    GDC-0853 was administered orally at a dose of 200mg, as per the dosing schedules described above.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Adverse Events (AEs)Time frame: Day 1 up until 8 weeks after the last dose of study drug (up to 1 year, 2 months)
  2. Percentage of Participants Achieving American College of Rheumatology 50% (ACR50) Response at Week 52Time frame: Week 52

Locations

104 sites in 10 countries. Site status is shown where the registry gives one.

  • Arizona Arthritis & Rheumatology Associates, P.C.

    Glendale, Arizona

  • Medvin Clinical Research

    Covina, California

  • TriWest Research Associates, LLC

    El Cajon, California

  • Saint Jude Heritage Medical Grp

    Fullerton, California

  • RASF-Clinical Research Center

    Boca Raton, Florida

  • Clinical Research of West Florida

    Clearwater, Florida

  • Medication Management

    Greensboro, North Carolina

  • Oregon Health & Science Uni

    Portland, Oregon

  • Metroplex Clinical Research Centre

    Dallas, Texas

  • Baylor Research Inst.

    Dallas, Texas

  • Accurate Clinical Research

    Houston, Texas

  • Instituto de Investigaciones Clinicas-Mar del Plata

    Buenos Aires, Argentina

  • APRILLUS

    Buenos Aires, Argentina

  • Instituto centenario

    Buenos Aires, Argentina

  • Centro de Investigacion en Enfermedades Reumaticas CIER

    Ciudad Autonoma Buenos Aires, Argentina

  • Expertia S.A- Mautalen Salud e Investigación

    Ciudad Autonoma Buenos Aires, Argentina

  • CCBR - Buenos Aires - AR; AxisMed SRL

    Ciudad Autonoma Buenos Aires, Argentina

  • ILAIM-CEOM Inst. Latinoamericano de Inv. Medicas

    Córdoba, Argentina

  • Centro de Investigaciones Medicas Mar Del Plata

    Mar del Plata, Argentina

  • Instituto de Investigaciones Clinicas

    Rosario, Argentina

  • CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica

    San Juan, Argentina

  • Centro Medico Privado de Reumatologia; Reumathology

    San Miguel, Argentina

  • CIP - Centro Internacional de Pesquisa X; Pesquisa Clinica

    Goiânia, Goiás, Brazil

  • CMiP - Centro Mineiro de Pesquisa*X*

    Juiz de Fora, Minas Gerais, Brazil

  • Centro de Estudos em Terapias Inovadoras - CETI

    Curtiba, Paraná, Brazil

  • CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda.

    Rio de Janeiro, Rio de Janeiro, Brazil

  • LMK Serviços Médicos S/S

    Porto Alegre, Rio Grande do Sul, Brazil

  • CAEP - Centro Avancado de Estudos e Pesquisas Ltda.

    Campinas, São Paulo, Brazil

  • IMA Brasil - Instituto de Medicina Avancada

    São Paulo, São Paulo, Brazil

  • MHAT "Eurohospital" - Plovdiv, OOD; Internal Department

    Plovdiv, Bulgaria

  • UMHAT "Kaspela", EOOD

    Plovdiv, Bulgaria

  • Medizinski Zentrar-1-Sevlievo EOOD

    Sevlievo, Bulgaria

  • MHAT "Hadzhi Dimitar", OOD

    Sliven, Bulgaria

  • Medical Center Excelsior OOD

    Sofia, Bulgaria

  • NMTH "Tsar Boris III"

    Sofia, Bulgaria

  • DCC "Alexandrovska", EOOD; Clinic of Neurology

    Sofia, Bulgaria

  • MC "Synexus - Sofia", EOOD

    Sofia, Bulgaria

  • UMHAT "SofiaMed", OOD; Department of Neurology

    Sofia, Bulgaria

  • Centro de Investigacion Medico Asistencial S.A.S

    Barranquilla, Colombia

  • Centro de Investigacion en Reumatologia y Especialdades Medicas SAS. CIREEM

    Bogotá, Colombia

Showing 40 of 104 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.